Research ArticlePhysics/Instrumentation
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
Jimson W. D’Souza, Harvey Hensley, Mohan Doss, Charles Beigarten, Michael Torgov, Tove Olafsen, Jian Q. Yu and Matthew K. Robinson
Journal of Nuclear Medicine January 2017, 58 (1) 175-180; DOI: https://doi.org/10.2967/jnumed.116.178780
Jimson W. D’Souza
1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Harvey Hensley
1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
Mohan Doss
1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
2Nuclear Medicine, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and
Charles Beigarten
3ImaginAb Inc., Inglewood, California
Michael Torgov
3ImaginAb Inc., Inglewood, California
Tove Olafsen
3ImaginAb Inc., Inglewood, California
Jian Q. Yu
1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania
2Nuclear Medicine, Department of Diagnostic Imaging, Fox Chase Cancer Center, Philadelphia, Pennsylvania; and
Matthew K. Robinson
1Molecular Therapeutics Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 1
January 1, 2017
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
Jimson W. D’Souza, Harvey Hensley, Mohan Doss, Charles Beigarten, Michael Torgov, Tove Olafsen, Jian Q. Yu, Matthew K. Robinson
Journal of Nuclear Medicine Jan 2017, 58 (1) 175-180; DOI: 10.2967/jnumed.116.178780
Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-Based PET Radiotracers
Jimson W. D’Souza, Harvey Hensley, Mohan Doss, Charles Beigarten, Michael Torgov, Tove Olafsen, Jian Q. Yu, Matthew K. Robinson
Journal of Nuclear Medicine Jan 2017, 58 (1) 175-180; DOI: 10.2967/jnumed.116.178780